Shanghai United Imaging Healthcare Co., Ltd. (688271.SH) Latest Company News

Oct 29, 2026, 06:27 UTC
United Imaging Healthcare and Walk Again Project signed a strategic cooperation agreement focused on imaging in the brain-computer interface field.
Source:
- finance.sina.cn
Oct 28, 2026, 08:27 UTC
United Imaging Healthcare reported third-quarter 2026 revenue of 3.529 billion yuan, up 24.12% year over year, and net profit attributable to shareholders of 138 million yuan, up 13%.
Source:
- finance.sina.cn
Oct 8, 2026, 08:11 UTC
United Imaging Healthcare established Huangshi Lianhao Technology Co., Ltd., which it indirectly wholly owns, with registered capital of 15 million yuan and businesses including special ceramic products manufacturing.
Source:
- finance.sina.cn
Sep 14, 2026, 11:38 UTC
Soochow University's State Key Laboratory of Radiation Medicine and Protection signed a joint open research project agreement with United Imaging Healthcare and launched industry-academia-research-medical collaboration on "micro-dose" DR imaging technology on September 13, 2026.
Source:
- finance.sina.cn
Sep 14, 2026, 11:38 UTC
United Imaging Healthcare unveiled its "micro-dose" DR imaging technology at an industry-academia-research-medical seminar on September 13, 2026.
Source:
- finance.sina.cn
Sep 1, 2026, 08:40 UTC
United Imaging Healthcare announced that as of August 31, 2026, it had repurchased 2,624,232 shares totaling 283 million yuan, with a planned total buyback of 300-600 million yuan for employee stock plans or equity incentives.
Source:
- finance.sina.cn
Aug 19, 2026, 09:01 UTC
United Imaging Healthcare announced its 2026 half-year results: revenue of 7.052 billion yuan, up 17.22% year-on-year; net profit attributable to shareholders of 897 million yuan, down 10.12% year-on-year; non-GAAP net profit of 827 million yuan, down 14.38% year-on-year.
Source:
- finance.sina.cn
Aug 19, 2026, 09:01 UTC
United Imaging Healthcare announced an interim dividend of 1.3 yuan per 10 shares (tax inclusive), totaling 106 million yuan.
Source:
- finance.sina.cn
Jun 2, 2026, 11:00 UTC
Telix Pharmaceuticals and United Imaging Healthcare North America signed a Memorandum of Understanding to evaluate a strategic research collaboration in the United States focused on advancing integrated theranostics solutions.
Source:
- globenewswire.com

688271.SH

United Imaging Healthcare and Walk Again Project signed a strategic cooperation agreement focused on imaging in the brain-computer interface field.

United Imaging Healthcare reported third-quarter 2026 revenue of 3.529 billion yuan, up 24.12% year over year, and net profit attributable to shareholders of 138 million yuan, up 13%.

United Imaging Healthcare established Huangshi Lianhao Technology Co., Ltd., which it indirectly wholly owns, with registered capital of 15 million yuan and businesses including special ceramic products manufacturing.

Soochow University's State Key Laboratory of Radiation Medicine and Protection signed a joint open research project agreement with United Imaging Healthcare and launched industry-academia-research-medical collaboration on "micro-dose" DR imaging technology on September 13, 2026.

United Imaging Healthcare unveiled its "micro-dose" DR imaging technology at an industry-academia-research-medical seminar on September 13, 2026.

United Imaging Healthcare announced that as of August 31, 2026, it had repurchased 2,624,232 shares totaling 283 million yuan, with a planned total buyback of 300-600 million yuan for employee stock plans or equity incentives.

United Imaging Healthcare announced its 2026 half-year results: revenue of 7.052 billion yuan, up 17.22% year-on-year; net profit attributable to shareholders of 897 million yuan, down 10.12% year-on-year; non-GAAP net profit of 827 million yuan, down 14.38% year-on-year.

United Imaging Healthcare announced an interim dividend of 1.3 yuan per 10 shares (tax inclusive), totaling 106 million yuan.

Telix Pharmaceuticals and United Imaging Healthcare North America signed a Memorandum of Understanding to evaluate a strategic research collaboration in the United States focused on advancing integrated theranostics solutions.